Skip to main content
SpringerLink
Log in

38 De implanteerbare cardioverter-defibrillator

  • Chapter
Cardiologie

Part of the book series: Quintessens ((QUI))

  • 3396 Accesses

Samenvatting

In Nederland worden jaarlijks 20.000-30.000 mensen getroffen door een acute circulatie- en ademstilstand. Bij 80% van hen wordt de circulatiestilstand veroorzaakt door een ventriculaire ritmestoornis (ventrikeltachycardie of -fibrilleren: VT/VF). Bij 50% is de aritmie het gevolg van acute ischemie en bij 50% wordt de ritmestoornis niet geluxeerd door ischemie. Momenteel wordt slechts 2-5% van deze patiënten met succes gereanimeerd en opgenomen in een ziekenhuis. De patiënten zonder acute ischemie hebben een kans op een recidief van de ritmestoornis van 20-40% per jaar.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Literatuur

  • Bardy G, Lee K, Mark D, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Eng J Med. 2005;352:225–37.

    Article  CAS  Google Scholar 

  • Borger van der Burg AE, Bax JJ, Boersma E, et al. Impact of viability, ischemia, scar tissue, and revascularization on outcome after aborted sudden death. Circulation. 2003;108:1954–9.

    Article  Google Scholar 

  • Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Eng J Med. 2004;350:2140–50.

    Article  CAS  Google Scholar 

  • Buxton A, Lee K, Fisher J, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Eng J Med. 1999;341:1882–90.

    Article  CAS  Google Scholar 

  • Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Eng J Med. 2005;352:1539–49.

    Article  CAS  Google Scholar 

  • Gatzoulis MA, Till JA, Sommerville J, Redington AN. Mechanoelectrical interaction in tetralogy of Fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation. 1995;92:231–7.

    Article  CAS  PubMed  Google Scholar 

  • Gould PA, Krahn AD, Canadian Heart Rhythm Society Working Group on Device Advisories. Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. JAMA. 2006;295:1907–11.

    Google Scholar 

  • Kadish A, Dyer A, Daubert J, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Eng J Med. 2004;350:2151–8.

    Article  CAS  Google Scholar 

  • Kies P, Boersma E, Bax JJ, et al. Determinants of recurrent ventricular arrhythmia or death in 300 consecutive patients with ischemic heart disease who experienced aborted sudden death: data from the Leiden out-of-hospital cardiac arrest study. J Cardiovasc Electrophysiol. 2005;16:1049–56.

    Article  PubMed  Google Scholar 

  • Kies P, Bootsma M, Bax J, et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: screening, diagnosis, and treatment. Heart Rhythm. 2006;3:225–34.

    Article  PubMed  Google Scholar 

  • Maron BJ, Shen WK, Link MS, et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Eng J Med. 2000;342:365–73.

    Article  CAS  Google Scholar 

  • Mirowski M, Reid PR, Mower MM, et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Eng J Med. 1980;303:322–4.

    Article  CAS  Google Scholar 

  • Moss A, Hall J, Cannom D, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk of ventricular arrhythmias. N Eng J Med. 1996;335:1933–40.

    Article  CAS  Google Scholar 

  • Moss A, Zareba W, Hall WJ, Klein H, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Eng J Med. 2002;346:877–83.

    Article  Google Scholar 

  • Rooden CJ van, Molhoek SG, Rosendaal FR. Incidence and risk factors of early venous thrombosis associated with permanent pacemaker leads. J Cardiovasc Electrofysiol. 2004;15:1258–62.

    Article  Google Scholar 

  • Silka MJ, Hardy BG, Menashe VD, Morris CD. A population-based prospective evaluation of risk of sudden death after operation for common congenital heart defects. J Am Coll Cardiol. 1998;32:45–51.

    Google Scholar 

  • The Antiarrhythmic Versus Implantable Defibrillator (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Eng J Med. 1997;337:1576–83.

    Google Scholar 

  • Wever EF, Hauer RN, Oomen J, et al. Unfavorable outcome in patients with primary electrical disease who survived an episode of ventricular fibrillation. Circulation. 1993;88:1021–9.

    Article  CAS  PubMed  Google Scholar 

  • Yap SC, Roos-Hesselink JW, Hoendermis ES, et al. Outcome of implantable cardioverter defibrillators in adults with congenital heart disease: a multi-centre study. Eur Heart J. 2007;28:1854–61.

    Article  PubMed  Google Scholar 

  • Zwanziger J, Hall J, Dick AW, et al. The cost effectiveness of implantable cardioverter-defibrillators: Results from the Multicenter Automatic Defribillator Implantation Trial (MADIT II). J Am Coll Cardiol. 2006;47:2310–18.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Leids Universitair Medisch Centrum, Leiden

    Prof.Dr. M. J. Schalij & Dr. L. Van Erven

Authors
  1. Prof.Dr. M. J. Schalij
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dr. L. Van Erven
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Leids Universitair Medisch Centrum, Leiden

    E. E. Van Der Wall

  2. ICIN, KNAW, Utrecht

    E. E. Van Der Wall

  3. Universitaire Ziekenhuizen Leuven, Leuven

    F. Van De Werf

  4. Universitair Medisch Centrum Groningen, Groningen

    F. Zijlstra

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Bohn Stafleu van Loghum, Houten

About this chapter

Cite this chapter

Schalij, M.J., Van Erven, L. (2008). 38 De implanteerbare cardioverter-defibrillator. In: Van Der Wall, E.E., Van De Werf, F., Zijlstra, F. (eds) Cardiologie. Quintessens. Bohn Stafleu van Loghum, Houten. https://doi.org/10.1007/978-90-313-7029-0_38

Download citation

  • DOI: https://doi.org/10.1007/978-90-313-7029-0_38

  • Publisher Name: Bohn Stafleu van Loghum, Houten

  • Print ISBN: 978-90-313-4829-9

  • Online ISBN: 978-90-313-7029-0

  • eBook Packages: Dutch language eBook collection

Publish with us

Policies and ethics

Search

Navigation